CAD improves detection of inconspicuous colonic polyps, adds little to search for flat colorectal lesions
Computer-aided detection systems show high potential for detecting inconspicuous colonic polyps but provide little help in locating nonpolypoid colorectal lesions, according to research presented Wednesday at the RSNA meeting.
Computer-aided detection systems show high potential for detecting inconspicuous colonic polyps but provide little help in locating nonpolypoid colorectal lesions, according to research presented Wednesday at the RSNA meeting.
Results of a study of 411 patients with three of the most conspicuous types of polyps -- near folds, on folds, and on walls -- showed high sensitivity for all three types, regardless of the polyp's conspicuity.
However, another study in the session, comparing the sensitivity of CT colonoscopies read by human readers with computer-aided diagnoses for detecting nonpolypoid (flat) colorectal lesions, showed that human readers had a 67% detection rate, compared to 56% for CAD.
The study noted, however, that using CAD software may help lower human perceptive errors and reduce reporting time.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
